Literature DB >> 2500680

Elevated VIP and endotoxin plasma levels in human gram-negative septic shock.

P Brandtzaeg1, O Oktedalen, P Kierulf, P K Opstad.   

Abstract

Vasoactive intestinal polypeptide (VIP) and endotoxin (lipopolysaccharides, LPS) were measured in plasma samples from 11 patients with bacteriologically verified meningococcal disease. Five patients suffered fulminant septicaemia, developed severe septic shock, and 2 died due to circulatory collapse. Initially, all 5 had levels of VIP above 4 pM and plasma endotoxin above 200 ng/liter. Five patients were diagnosed as meningitis and 1 as having meningococcaemia, all with a normal circulatory state. None of these 6 patients had initially levels of VIP above 2.5 pM or endotoxin levels above 25 ng/liter (P less than 0.001). A correlation existed between plasma endotoxin and VIP levels (r = 0.735, P = 0.01). Sequentially collected samples from 3 patients showed rapidly declining VIP levels after initiation of antibiotic and fluid treatment. These results are in agreement with previous animal experiments, suggesting that endotoxin directly or indirectly stimulates the VIP-ergic nervous system in the initial phase of gram-negative septic shock in man.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500680     DOI: 10.1016/0167-0115(89)90209-7

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  17 in total

1.  Outer membrane protein A, peptidoglycan-associated lipoprotein, and murein lipoprotein are released by Escherichia coli bacteria into serum.

Authors:  J Hellman; P M Loiselle; M M Tehan; J E Allaire; L A Boyle; J T Kurnick; D M Andrews; K Sik Kim; H S Warren
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

Review 2.  Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.

Authors:  Mario Delgado; Doina Ganea
Journal:  Amino Acids       Date:  2011-12-03       Impact factor: 3.520

3.  Inhibition of vasoactive intestinal polypeptide (VIP) induces resistance to dextran sodium sulfate (DSS)-induced colitis in mice.

Authors:  John P Vu; Mulugeta Million; Muriel Larauche; Leon Luong; Joshua Norris; James A Waschek; Charalabos Pothoulakis; Joseph R Pisegna; Patrizia M Germano
Journal:  J Mol Neurosci       Date:  2014-01-07       Impact factor: 3.444

4.  Effects of sepsis on mast cells in rat dura mater: influence of L-NAME and VIP.

Authors:  F Tore; A M Reynier-Rebuffel; N Tuncel; J Callebert; P Aubineau
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

5.  Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor.

Authors:  Carmen Martinez; Catalina Abad; Mario Delgado; Alicia Arranz; Maria G Juarranz; Nieves Rodriguez-Henche; Philippe Brabet; Javier Leceta; Rosa P Gomariz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

6.  An assessment of plasma histamine concentrations during documented endotoxic shock.

Authors:  D J Brackett; S A Hamburger; M R Lerner; S B Jones; C F Schaefer; D P Henry; M F Wilson
Journal:  Agents Actions       Date:  1990-11

7.  Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy.

Authors:  P Brandtzaeg; K Bryn; P Kierulf; R Ovstebø; E Namork; B Aase; E Jantzen
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1.

Authors:  Alejo Chorny; Mario Delgado
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

9.  Circulating levels of vasoactive peptides in patients with acute bacterial meningitis.

Authors:  Ronan M G Berg; Gitte Irene Strauss; Flemming Tofteng; Tavs Qvist; Lars Edvinsson; Jan Fahrenkrug; Jesper Qvist; Lise Fonsmark; Peter Skinhøj; Kirsten Møller
Journal:  Intensive Care Med       Date:  2009-06-10       Impact factor: 17.440

Review 10.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.